Cargando…
Clinical results of carbon-ion radiotherapy for stage I non-small cell lung cancer with concomitant interstitial lung disease: a Japanese national registry study (J-CROS-LUNG)
Anti-cancer treatments for lung cancer patients with interstitial lung disease (ILD) are challenging. The treatment options for ILD are often limited because of concerns that treatments can cause acute exacerbation (AE) of ILD. This study aimed to analyze the outcomes of carbon-ion radiotherapy (CIR...
Autores principales: | Okano, Naoko, Suefuji, Hiroaki, Nakajima, Mio, Tokumaru, Sunao, Kubo, Nobuteru, Yoshida, Daisaku, Suzuki, Osamu, Ishikawa, Hitoshi, Satouchi, Miyako, Nakayama, Haruhiko, Shioyama, Yoshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278880/ https://www.ncbi.nlm.nih.gov/pubmed/37036751 http://dx.doi.org/10.1093/jrr/rrad008 |
Ejemplares similares
-
A retrospective multicenter study of carbon‐ion radiotherapy for major salivary gland carcinomas: Subanalysis of J‐CROS 1402 HN
por: Hayashi, Kazuhiko, et al.
Publicado: (2018) -
Concomitant Interstitial Lung Disease with Psoriasis
por: Ishikawa, Genta, et al.
Publicado: (2019) -
Efficacy and Safety of Carbon-Ion Radiotherapy for Stage I Non-Small Cell Lung Cancer with Coexisting Interstitial Lung Disease
por: Okano, Naoko, et al.
Publicado: (2021) -
Nationwide survey of radiation therapy in Japan for lung cancer complicated with interstitial lung disease
por: Hagiwara, Yasuhito, et al.
Publicado: (2020) -
Corrigendum to: Nationwide survey of radiation therapy in Japan for lung cancer complicated with interstitial lung disease
por: Hagiwara, Yasuhito, et al.
Publicado: (2020)